Agevisa/PB Takes Action to Combat Smoking in Paraiba Region

Sep.01.2022
Agevisa/PB Takes Action to Combat Smoking in Paraiba Region
Brazil's Agevisa reinforces actions against smoking in Paraíba and emphasizes partnerships for health protection and environmental sustainability.

The Brazilian National Health Surveillance Agency (Agevisa) has been strengthening its actions and partnerships aimed at combating smoking in the Paraiba region throughout the year. On August 29th (National Day to Combat Tobacco), General Director Geraldo Moreira de Menezes outlined measures that not only aim to educate the public about the serious harm caused by tobacco products but also to train collaborating organizations to better protect human health and the state's environment.


He emphasized the importance of establishing partnerships between the State Health Surveillance Agency, Procon/PB, the Public Department, state and federal police, Sudema/PB, the Federal Revenue Service, and other state health agencies (members of this structure). This Agency has been providing advice on the implementation and execution of a quality management system for Agevisa/PB, which has yielded very positive results. The improvement of this Agency's activities in promoting and protecting human health in Paraíba has been positively impacted.


From August 22 to 25, Agevisa/PB actively participated in a training program on tobacco control legislation and inspection for health supervisors and Procons professionals in Paraiba. The event was held online and was co-organized by the National Cancer Institute (Inca), the National Health Surveillance Agency (Anvisa), and the Pan American Health Organization (PAHO).


Helena Teixeira de Lima Barbosa, the Technical Director of Agevisa/PB's Medical Science and Technology and Related department, discussed the role of health monitoring in tobacco control. She focused on the responsibilities and challenges facing regulators and highlighted the importance of societal awareness and participation in the fight against smoking. In her speech, Helena discussed Paraiba's health surveillance actions, responsibilities, legal documents, and experiences in combating smoking. She emphasized the extreme damage to health and the environment caused by the many substances in tobacco products, including electronic cigarette devices, also known as e-cigarettes.


According to Geraldo Moreira, this year Agevisa/PB has also promoted tobacco product inspection training for coordinators and municipal health inspectors to expand and improve the promotion and protection of public health in the region.


On June 14th and 15th, training was held for public health surveillance professionals in National Health Zones 1, 12, and 14. On March 30th, a training session was conducted for Visas staff from various cities in the second health zone during an event in Guarabira/PB.


Sustainability and tobacco control - Agevisa/PB is also actively involved in the National Cancer Institute's technical visit program to Paraiba to introduce sustainable tobacco control projects. From June 27th to July 1st, 2022, representatives from INCA, PAHO, the Secretary of State, and the Municipal Health Secretary discussed the project, Agevisa/PB, Empresa Paraibana de Turismo (PBTur), and tourism in the capital of Paraiba at the Casa de Jose Americo Foundation in João Pessoa/PB.


Geraldo Moreira de Menezes, the director general of Agevisa/PB, attended the event and emphasized the state government's commitment to expanding efforts to combat smoking in Paraiba. He discussed the agency's responsibility for oversight and education, and pointed out their concerns about the growth of smoking, including hookah and e-cigarettes.


Confiscation of electronic cigarettes - as part of a permanent effort to combat smoking in Paraiba, the director of Agevisa/PB emphasized on the 29th that the working group, which was launched on June 30th in João Pessoa/PB, seized a large number of electronic smoking devices at a tobacco store near Tambau. The owner of the establishment was arrested at the time and taken to the Federal Police Headquarters for questioning.


Késsia Liliana, the head of Procon/PB, Hugo José de Barros Franca, the health technology director, and Ado Augusto Bezerra de Brito, the health risk inspection and control technology manager from Agevisa attended this operation. PB, Procon inspectors, and federal police agent Geraldo Moreira announced an intensified inspection and imposed sanitary penalties on those responsible for public or private collective-use environments allowing the use of electronic cigarettes, vaporizers, vapes, and e-cigarettes throughout the state of Paraiba. The use of cigarettes, electronic cigarettes, e-cigarettes, or any other electronic smoking device (DEF) is prohibited in environments under their responsibility.


According to Geraldo Moreira, the initiative of Law 12,351/2022 aims to strengthen Paraiba's struggle against smoking by creating a smoke-free environment for collective use, considering whether Law 1 originated from smoke.


Disclaimer: 1. The content of this article is compiled from third-party information and is only for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS is also unable to confirm the truthfulness and accuracy of the content. The compile of this article is only for industry exchange and research purposes. 3. Due to the limited compilation level, the compiled article may not express the same meaning as the original, please refer to the original article for accuracy. 4. Regarding any domestic, Hong Kong, Macao, Taiwan, and foreign expressions and positions, 2FIRSTS maintains full consistency with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Limited, a wholly owned subsidiary of AIR Global, has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million and a Ba3 rating. AIR had about $412.4 million outstanding under the two bank facilities at June 30 and net debt of $344.8 million. In the first half of 2026, AIR's Al Fakher-led flavored shisha molasses business generated about 99% of company revenue, while New Growth Categories including Crown Switch produced $2.2 million in revenue and remained loss-making on an adjusted EBITDA basis.
Sep.23
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia's new retail tobacco permit system took effect October 1, requiring sellers of vapes, nicotine products and related devices and accessories to obtain a Retail Tobacco Permit for each business location. Virginia ABC said more than 3,000 businesses applied in September alone, creating a processing backlog. Qualifying applicants that filed before October 1 may temporarily operate under a Letter of Authorization. The new store-level permit also sits alongside Virginia's existing vape product directory, where sales of unlisted liquid nicotine or nicotine vapor products can trigger civil penalties starting at $5,000.
Regulations
Oct.03
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04